The Department set up a guidance development group in July 2017 to develop guidance for schools in England on adrenaline auto-injectors (AAIs) in anticipation of the introduction of the Human Medicines (Amendment) Regulations 2017. The guidance is non-statutory and aims to capture the good practice which schools in England should observe in using spare AAIs. Schools may wish to use this as the basis of any protocol or policy.
The guidance development group included representatives of the devolved administrations. The guidance was intended for use in England, but can be used by the devolved administrations if they wish, or to help inform their own guidance. The Scottish Government will be publishing its own guidance for schools shortly.